Cheapest GLP-1 Injections 2026: Most Affordable Semaglutide & Tirzepatide
Cheapest GLP-1 injections May 2026: Trimi $99/mo sema, $125/mo tirz (annual). Henry Meds and Mochi compared head-to-head with verified pricing.
Quick answer
Among the compounded GLP-1 telehealth providers compared here for 2026, the lowest verified price is Trimi's compounded semaglutide at a flat $99/month on annual billing ($1,188/year, all-inclusive, a 12-month commitment). Compounded tirzepatide is next at $125/month annual. Both are prepared per individual prescription at state-licensed 503A compounding pharmacies; compounded preparations are not FDA-approved as drugs.
Written by Trimi Medical Team
Medically reviewed by Dr. Sean Arora, MD
More on GLP-1 Cost & Access
Best Compounded GLP-1 Providers
Ranked comparison of all compounded GLP-1 telehealth platforms.
Weight Loss Injection Costs
Complete breakdown of every GLP-1 injection cost.
Cheapest Legal GLP-1 Online (50 States, 2026)
Definitive cornerstone, pricing comparison, legal framework, pharmacy compliance citations.
What Are the Cheapest GLP-1 Injections in 2026?
The cheapest GLP-1 injections among the compounded telehealth providers compared here in 2026 are compounded semaglutide and compounded tirzepatide from providers that partner with state-licensed 503A community sterile compounding pharmacies. These compounded preparations are made against an individual prescription rather than manufactured and marketed as FDA-approved finished drugs like Wegovy (semaglutide) and Zepbound (tirzepatide), which are approved, labeled, and distributed under an entirely separate federal framework.
In practical terms, the most affordable compounded semaglutide starts at $99/month through providers like Trimi, and compounded tirzepatide starts at $125/month. Both are flat cash-pay rates that include the provider consultation and shipping, so the number you are quoted is the number you pay -- no deductible, no prior authorization, and no formulary appeal.
What Are Compounded GLP-1s?
Compounded GLP-1 medications are produced by licensed U.S. compounding pharmacies. There are two regulatory tiers: 503A community sterile compounding pharmacies, which are licensed by their state board of pharmacy and prepare patient-specific prescriptions under USP <797> sterile-compounding standards; and 503B outsourcing facilities, which are registered with the FDA and manufacture in bulk under current Good Manufacturing Practice (cGMP) standards with regular FDA inspections. Trimi partners with a 503A community sterile compounding pharmacy (BelieveRx, TX #35264).
These pharmacies are legally permitted to compound medications when the commercially available version faces documented shortages or when a specific patient need exists that the approved product cannot meet. A compounded preparation is not an FDA-approved drug: it has not been evaluated by FDA for safety, effectiveness, or manufacturing quality.
The GLP-1 medication class -- which includes semaglutide, tirzepatide, and liraglutide -- has produced some of the most significant weight loss outcomes ever documented in clinical trials. Semaglutide demonstrated 14.9% average body weight reduction in the STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021), while tirzepatide achieved 20.9% in SURMOUNT-1 (Jastreboff et al., New England Journal of Medicine, 2022). These results were previously achievable only through bariatric surgery. Access has always been the hard part -- and in 2026 there are more prescribing pathways open to patients than there were two years ago.
2026 GLP-1 Provider Price Comparison: Full Rankings
The following table compares selected telehealth providers offering compounded GLP-1 injections in 2026, ranked by lowest semaglutide price. All prices reflect publicly available cash-pay rates as of April 2026. We include consultation fees, contract requirements, and projected 12-month totals to give you the true all-in cost.
| Provider | Semaglutide/mo | Tirzepatide/mo | Consultation | Contract | 12-Month Total |
|---|---|---|---|---|---|
| TrimiLowest price | $99 | $125 | Free | Annual plan: 12 months; month-to-month available | $1,188 |
| Found | $129-$199 | $199-$299 | Included | Monthly | $1,548-$2,388 |
| Henry Meds | $199-$349 | $299-$449 | $49-$99 | Monthly | $2,388-$4,188+ |
Prices reflect publicly listed cash-pay rates as of April 2026 and are subject to change. The 12-month total is calculated using the lowest available monthly medication price plus any stated consultation fees. Confirm current pricing directly with each provider before enrolling.
Key Takeaway
Trimi offers the lowest flat-rate pricing among the compounded providers in this table for both semaglutide ($99/mo) and tirzepatide ($125/mo) with no consultation fee and no membership fee.
Breaking Down the Cost Differences
The price variation across providers comes down to several factors. Some providers like Found price their lower doses competitively but charge significantly more as patients titrate to higher, maintenance-level doses. This means the $129 starting price may climb to $199+ within a few months. Trimi maintains the same flat rate regardless of dose, which is a meaningful difference over a full treatment course.
Hidden costs also play a role. Henry Meds charges a separate consultation fee of $49-$99 on top of medication pricing. As of October 2026, Calibrate's Metabolic Reset membership has an initial 3-month commitment and then renews monthly, and lab tests and prescription medications are not included. For an in-depth review of Calibrate's pricing structure, see our Calibrate cost breakdown.
Contract requirements matter as well. Trimi's month-to-month plans can be cancelled at any billing cycle, while the annual plan is a 12-month commitment. As of October 2026, Calibrate's membership starts with an initial 3-month commitment, and WW Med+ plans (formerly Sequence) run 6 or 12 months and auto-renew unless canceled. If you are unsure how long you will need treatment or want to test a provider before committing, month-to-month flexibility is essential. For a side-by-side comparison of these program structures, see our best compounded GLP-1 providers guide.
How Brand-Name GLP-1 List Pricing Is Set
Brand-name GLP-1 list prices are published, and knowing them helps when you are negotiating coverage with an insurer or reading a pharmacy quote. Brand-name Wegovy carries a list price of approximately $1,100-$1,350 per month. Brand-name Zepbound (tirzepatide for obesity) runs $1,000-$1,300 monthly. Even with manufacturer savings cards, many patients pay $300-$500/month out of pocket after insurance.
Compounding pharmacies operate under a fundamentally different model than pharmaceutical manufacturers like Novo Nordisk and Eli Lilly: they prepare medication against individual prescriptions rather than manufacturing and marketing an FDA-approved finished drug, and a compounded preparation is not FDA-approved. Here is what goes into a brand list price:
R&D and trial recovery
Novo Nordisk spent billions developing semaglutide through Phase 1-3 clinical trials, FDA approval processes, and post-market surveillance studies. Brand-name pricing recovers that investment across the patent period.
Patent protection
Brand-name medications carry patent-protected pricing that limits competition. Pharmacy compounding sits in a separate legal pathway that allows preparation only when shortage or individual clinical-need conditions are met; it is not a generic and does not create regulatory competition.
Direct-to-consumer marketing
Pharmaceutical companies spend hundreds of millions annually on TV advertising, provider outreach, and promotional campaigns, and that spend is built into the list price.
Insurance rebate dynamics
Brand list prices are set with expected pharmacy benefit manager rebates and manufacturer discounts already factored in. Cash-pay patients generally never see those discounts, which is why the sticker price and the negotiated net price diverge so widely.
It is important to understand the two regulatory tiers of compounding pharmacy. 503A community sterile compounding pharmacies, the tier Trimi partners with (BelieveRx, TX #35264), are licensed by their state board of pharmacy and prepare patient-specific prescriptions under USP <797> sterile-compounding standards, with third-party batch testing for potency and sterility. 503B outsourcing facilities are a separate tier, registered with the FDA and subject to current Good Manufacturing Practice (cGMP) standards and FDA inspections for bulk production. Both frameworks exist to ensure quality and patient safety.
For a deeper look at how compounded semaglutide compares to brand-name Wegovy in terms of clinical performance, see our compounded vs brand-name semaglutide comparison.
What to Look For in an Affordable GLP-1 Provider
Not all low-cost GLP-1 providers are equal. Price should not be the only factor when choosing where to get your medication. The following checklist covers the essential criteria that separate reputable affordable providers from those cutting corners on quality or safety.
Provider Quality Checklist
503A sterile compounding pharmacy partner
Ensures state board of pharmacy licensure, USP <797> sterile-compounding standards, and batch testing for potency and sterility. This is the single most important quality indicator. (FDA registration and cGMP apply to the separate 503B outsourcing-facility tier.)
Licensed prescribers in your state
Your prescribing provider must hold an active medical license in the state where you reside. Legitimate platforms verify this and will not prescribe across unlicensed state lines.
No hidden fees or upsells
The quoted medication price should be your total cost. Watch for separate consultation fees, enrollment fees, shipping charges, or mandatory add-on supplements.
Clear billing and cancellation terms
Before you enroll, confirm whether a plan is billed month-to-month or as a fixed-term commitment, and when you can cancel.
Transparent dosing and titration protocol
A reputable provider follows standard titration schedules (starting low, increasing gradually) and will not jump you to high doses prematurely. Your provider should communicate the titration plan clearly.
Responsive medical support
You should have a clear channel to contact your prescribing provider with questions about side effects, dosing concerns, or treatment adjustments. Response times within 24-48 hours are the standard.
Flat-rate pricing across dose levels
Some providers charge more as your dose increases. Flat-rate pricing means your cost stays the same whether you are on 0.25mg or 2.4mg semaglutide, protecting you from surprise price increases during treatment.
Red Flags to Avoid
- Prices significantly below $80/month -- may indicate lower-quality compounding sources, diluted formulations, or unlicensed pharmacies without proper quality controls.
- No medical consultation required -- GLP-1 medications are prescription drugs that require a licensed provider to evaluate your medical history, contraindications, and eligibility.
- Refuses to name pharmacy partner -- any legitimate provider should openly disclose the state-licensed compounding pharmacy that compounds their medication.
- Guaranteed specific weight loss results -- individual results vary based on adherence, diet, exercise, and metabolic factors. No provider can guarantee a specific outcome.
- No follow-up or monitoring -- proper GLP-1 treatment requires ongoing provider oversight for dose adjustments, side effect management, and progress evaluation.
Trimi meets every criterion on this checklist: a 503A community sterile compounding pharmacy partner (BelieveRx, TX #35264), licensed providers in all operating states, flat-rate pricing ($99 semaglutide, $125 tirzepatide on the annual plan, a 12-month commitment; month-to-month plans can be cancelled at any billing cycle), no consultation fee, no membership fee, and responsive medical support included in the price. For detailed reviews of other providers, see our best online weight loss provider 2026 comparison.
Brand-Name vs Compounded: What the Evidence Covers
One of the most common questions about compounded GLP-1 injections is what the published evidence actually covers. The answer matters: the clinical trial program behind these medications studied the FDA-approved products, and compounded preparations have not been studied in trials of their own.
Those landmark trials tested FDA-approved finished drugs. When Wilding et al. published the STEP 1 results in the New England Journal of Medicine (2021), demonstrating that semaglutide 2.4mg produced 14.9% average body weight loss over 68 weeks with 86.4% of participants losing at least 5% of body weight, those outcomes describe the FDA-approved product that was studied.
Similarly, when Jastreboff et al. published the SURMOUNT-1 trial results in the New England Journal of Medicine (2022), showing that tirzepatide 15mg produced 20.9% average weight loss over 72 weeks with 56.7% of participants achieving at least 20% body weight reduction, those results were generated with the FDA-approved product studied in that trial.
Key Clinical Trial Outcomes
| Trial | Medication | Avg. Weight Loss | Duration | Citation |
|---|---|---|---|---|
| STEP 1 | Semaglutide 2.4mg | 14.9% | 68 weeks | Wilding et al., NEJM 2021 |
| SURMOUNT-1 | Tirzepatide 15mg | 20.9% | 72 weeks | Jastreboff et al., NEJM 2022 |
| SELECT | Semaglutide 2.4mg | 9.4% + CV benefit | 40 months | Lincoff et al., NEJM 2023 |
| SURMOUNT-2 | Tirzepatide 15mg (T2D) | 14.7% | 72 weeks | Garvey et al., Lancet 2023 |
The SELECT trial (Lincoff et al., New England Journal of Medicine, 2023) added an important dimension: semaglutide 2.4mg reduced major adverse cardiovascular events by 20% in patients with pre-existing cardiovascular disease over a median follow-up of 40 months. That finding comes from the FDA-approved product studied in SELECT and has not been replicated for any compounded preparation.
The practical implication is straightforward: compounded semaglutide from a state-licensed 503A community sterile compounding pharmacy is a separate, non-FDA-approved pathway that a licensed provider may consider, and it runs $99-$200/month. Compounded tirzepatide runs $125-$450/month. Neither has been evaluated in its own clinical trial, so discuss the tradeoffs with your provider before choosing. Read our tirzepatide vs semaglutide comparison to determine which molecule may be the better fit for your goals.
Provider-by-Provider Cost Breakdown
Trimi -- $99/month Semaglutide, $125/month Tirzepatide
Trimi is a purpose-built weight loss platform that offers the most consistently affordable pricing among the compounded providers compared here. The flat-rate model means your cost stays at $99/month for semaglutide or $125/month for tirzepatide regardless of your dose level. There are no consultation fees and no enrollment fees. The $99 and $125 rates are on the annual plan, a 12-month commitment, and month-to-month plans can be cancelled at any billing cycle. Medication ships from 503A sterile compounding pharmacies, and ongoing medical support is included in the price. Over 12 months of semaglutide treatment, the total cost is $1,188 -- the lowest all-in cost of the compounded providers compared here.
Found -- $129-$199/month Semaglutide
Found is a weight-loss-focused platform offering compounded semaglutide from $129/month and tirzepatide from $199/month, with consultations included. Found's approach includes behavioral health components and may prescribe non-GLP-1 medications (metformin, bupropion/naltrexone) if their providers determine a different medication is more appropriate. The 12-month cost range of $1,548-$2,388 places them in the mid-range of providers. See our Found promo code page for active discounts.
Henry Meds -- $199-$349/month Semaglutide
Henry Meds prices compounded semaglutide at $199-$349/month and tirzepatide at $299-$449/month. A separate consultation fee of $49-$99 adds to the initial cost. This makes Henry Meds one of the more expensive compounded GLP-1 options in 2026, with 12-month totals reaching $2,388-$4,188+. The platform does offer a more concierge-style experience with personalized provider attention.
Hims, Ro, Calibrate and WeightWatchers Clinic: Not Ranked Here
These four are not ranked in this compounded price comparison. In a March 2026 announcement, Hims said it would no longer advertise compounded GLP-1s, and its August 2026 SEC earnings release says it offers compounded GLP-1 access on a limited scale; in March and April 2026 announcements, Hims said its providers can prescribe Wegovy and Ozempic and send Zepbound prescriptions to LillyDirect. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy. Calibrate says it does not prescribe compounded GLP-1s, and Sequence is now WW Med+ through WeightWatchers Clinic, which says it prescribes only FDA-approved medications. All four bill a membership separately from medication, so check each provider's current pricing page; for Ro, see our Ro pricing guide.
The Bottom Line: Who Offers the Cheapest GLP-1 Injections?
After comparing the compounded providers above, Trimi offers the most consistently affordable GLP-1 injections in 2026. At $99/month for semaglutide and $125/month for tirzepatide -- with no consultation fees, no membership fee, and flat-rate pricing across all dose levels -- Trimi delivers the lowest all-in cost for patients who prioritize affordability without sacrificing quality of care.
The $1,188 annual cost for semaglutide through Trimi does not change as you titrate up. Every dollar you are not spending on a dose-tier increase is a dollar that can go toward the healthy food, protein supplements, and gym memberships that support long-term weight loss success.
Why Trimi Is the Most Affordable Compounded Choice Here
For patients ready to start treatment, Trimi's online consultation takes minutes to complete. A licensed provider reviews your medical history, and if appropriate, your medication ships directly to your door from a state-licensed 503A community sterile compounding pharmacy.
Frequently Asked Questions
What is the cheapest GLP-1 injection available in 2026?
Among the compounded GLP-1 telehealth providers compared here for 2026, the lowest verified price is Trimi's compounded semaglutide at a flat $99/month on annual billing, a 12-month commitment, all-inclusive. This price includes licensed provider oversight, medication from a 503A sterile compounding pharmacy, and free shipping.
How does compounded semaglutide differ from brand-name Wegovy?
Wegovy is an FDA-approved finished drug supported by its own clinical trial program, including STEP 1. Compounded semaglutide is prepared by a state-licensed 503A community sterile compounding pharmacy against an individual prescription; it is not FDA-approved as a drug and has not been studied in its own clinical trials, so the brand trial results should not be read as expected outcomes for a compounded preparation. A licensed provider decides whether treatment is appropriate for you.
How is brand-name Wegovy priced?
Brand-name Wegovy costs $1,100-$1,350/month because its price reflects Novo Nordisk's research and development investment, the cost of FDA approval, marketing, and patent-protected pricing. What an individual patient pays depends on insurance coverage and manufacturer savings programs.
Do I need insurance to get affordable GLP-1 injections?
No. Compounded GLP-1 injections through telehealth providers like Trimi do not require insurance. Trimi's cash-pay pricing is a flat $99-$125/month, quoted up front with no prior authorization, no formulary appeals, and no claims paperwork. That predictability is why many uninsured and underinsured patients look at the cash-pay route.
Are there hidden fees with cheap GLP-1 providers?
Some providers advertise low medication prices but add consultation fees ($49-$99), enrollment fees, or require multi-month commitments. Trimi includes the provider consultation in the medication price with no hidden fees and no membership fee; its $99 and $125 rates are on the annual plan, a 12-month commitment, and month-to-month plans can be cancelled at any billing cycle. Always verify total cost including all fees before starting treatment.
How do I know if a compounding pharmacy is legitimate?
Look for state-licensed 503A community sterile compounding pharmacies that compound under USP <797> sterile-compounding standards. Reputable providers will disclose their pharmacy partners and can confirm the pharmacy's state board of pharmacy license, third-party potency testing, and sterility testing. (Note: FDA registration and cGMP apply to the separate 503B outsourcing-facility tier, not to 503A pharmacies.) Avoid any provider that cannot identify their pharmacy source.
Can I switch GLP-1 providers?
Yes. If you are already on semaglutide or tirzepatide through another provider, you can apply to switch to a provider like Trimi. Your new provider will review your medical history, current medication and dose; compounded and brand-name products should not be assumed interchangeable.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. 2021;384(11):989-1002. (STEP 1 Trial)
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine. 2022;387(3):205-216. (SURMOUNT-1 Trial)
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." New England Journal of Medicine. 2023;389(24):2221-2232. (SELECT Trial)
- Garvey WT, Frias JP, Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes." The Lancet. 2023;402(10402):613-626. (SURMOUNT-2 Trial)
- U.S. Food and Drug Administration. "Compounding and the FDA: Questions and Answers." FDA Guidance Document, updated 2024.
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov.